Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US Capitol Capsule: Americans unwilling to sacrifice Medicare, but back better Part D deal

This article was originally published in Scrip

Executive Summary

While President Barack Obama last week acknowledged during his inaugural address that the US must make "hard choices to reduce the cost of health care and the size of the nation's deficit," he signaled he was unwilling to accomplish those goals by sacrificing entitlement programs, like Medicare – a position supported by a majority of Americans, according to a new poll.

You may also be interested in...

PhRMA/BIO Devise 'Principles' To End Off-Label Limbo

Tired of waiting for safe harbor protections about communicating to payers and prescribers about pharmacoeconomics and unapproved uses, PhRMA and BIO are trying to move discussion forward.

Moderna's Valera Takes mRNA Approach To Combat Zika

With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.

Allergan's Price Reform Pledge: Will Others Follow?

Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts